Patent · US Active

Binding polypeptides and uses thereof

US8957187B2 · kind B2 · utility

1Cited by
82References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2006
Grant dateFeb 17, 2015
Priority date
Expiry dateOct 23, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides antibodies or antigen binding fragments thereof to DR5 and HER-2. The antibodies and/or antigen binding fragments thereof comprise variant CDRs comprising highly restricted amino acid sequence diversity. The invention also provides these polypeptides as fusion polypeptides to heterologous polypeptides such as at least a portion of phage or viral coat proteins, tags and linkers. In addition, compositions and methods of use for treatment of cancer and immune related conditions are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.